載入中
NYSEHealthcareMedical - Devices
最新資料
US$68.89
+US$2.20 · +3.30%
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
前收盤價
US$68.89
+US$2.20 · +3.30%
盤前
US$69.00
+US$0.11 · +0.16%
10月12日 上午4:12 ET
盤中時間採用ET。市場資料可能有所延遲。
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
日內區間
目前US$68.89
52週區間
目前US$68.89
盤中時間採用ET。市場資料可能有所延遲。
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
日內區間
目前US$68.89
52週區間
目前US$68.89
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 9.12億 USD | 8.03億 USD | 6.25億 USD | 4.08億 USD | 2.33億 USD |
| 銷貨成本 | 1.33億 USD | 1.23億 USD | 9657.6萬 USD | 6611.5萬 USD | 3327.9萬 USD |
| 毛利 | 7.79億 USD | 6.8億 USD | 5.28億 USD | 3.42億 USD | 2億 USD |
| 研究與開發 | 1.03億 USD | 1.14億 USD | 1.17億 USD | 6864.5萬 USD | 3735萬 USD |
| 銷售、一般及管理費用 | 6.25億 USD | 5.3億 USD | 4.52億 USD | 3.21億 USD | 2.03億 USD |
| 營業費用 | 7.28億 USD | 6.44億 USD | 5.68億 USD | 3.89億 USD | 2.4億 USD |
| 利息收入 | 1753.6萬 USD | 2324.7萬 USD | 2056萬 USD | 505萬 USD | 12.5萬 USD |
| 利息支出 | 13.7萬 USD | 2.2萬 USD | — | 167.7萬 USD | 212.8萬 USD |
| 折舊和攤銷 | 1395.7萬 USD | 655萬 USD | 284.6萬 USD | 185.8萬 USD | 121.8萬 USD |
| 營業利益 | 5095.4萬 USD | 3608.3萬 USD | −4027.1萬 USD | −4759.2萬 USD | −3985萬 USD |
| 淨利 | 1.45億 USD | 5350.9萬 USD | −2115.3萬 USD | −4488.1萬 USD | −4204.2萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$62.55
下跌空間 9.20%| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2008年1月9日 | US$9.00Irregular | — | — |
除息 2008年1月9日
US$9.00
Irregular
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR1.15億0.11%1031.91億 USD0.06%US$137.55+0.17%
Vanguard Morningstar Total Stock Market ETFVTI5758.22萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM5086.87萬0.06%787.4億 USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB4172.08萬0.02%1853億 USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK2390.62萬0.05%447億 USD0.05%US$344.74+1.22%
Vanguard Extended Market ETFVXF1923.8萬0.02%954億 USD0.05%US$235+0.80%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1768.62萬0.11%158.4億 USD0.03%US$53.45+0.17%
iShares Russell 2000 Growth ETFIWO1549.34萬0.11%139.17億 USD0.24%US$356.78+0.94%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMiShares Russell 2000 Growth ETFIWOAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
